Bioavailability, Drug Delivery Systems and RNA

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Bioavailability

Drug Delivery Systems

RNA

The Power of Lipids: Enhancing Drug Delivery with Nanoparticles

Roots Analysis

MAY 21, 2024

Over the last decade, one of the major challenges faced by pharmaceutical companies across the globe is low drug solubility. In fact, it has been observed that around 40% of the pharmaceutical drugs approved by regulatory organizations exhibit poor bioavailability / solubility.

Drug Delivery

Drug Delivery Drugs Gene Therapy Bioavailability

Considerations for Neuroscience Trials with Intrathecal Delivery and Other Methods of Direct CNS Administration

XTalks

AUGUST 30, 2022

A major obstacle for CNS drug developers is the inability to target therapies to the CNS broadly (for instance, a therapy that is orally bioavailable as a pill and has difficulty crossing the blood-brain barrier) and certain CNS regions more specifically. The patients are waiting!

Trials

Trials Drug Delivery Drugs Gene

Clinical Research Informer

The Power of Lipids: Enhancing Drug Delivery with Nanoparticles

Considerations for Neuroscience Trials with Intrathecal Delivery and Other Methods of Direct CNS Administration

Stay Connected